RepliCel Life Sciences, Inc.

RepliCel Life Sciences, Inc.

RepliCel Life Sciences, Inc.

Overview
Date Founded

2011

Headquarters

570 Granville Street, Suite 900, Vancouver, BC, V6C 3P1, CAN

Type of Company

Public

Employees (Worldwide)

1

Industries

Pharmaceuticals
Hospitals & Patient Services
Metal Manufacturing & Products
Medical Support Services
Biotechnology

Company Description

RepliCel Life Sciences, Inc. is a regenerative medicine company, which engages in the development of autologous cell therapies that treat functional cellular deficits including chronic tendon injuries, androgenetic alopeci, and skin aging. Its products includes RCT-01, RCS-01, and RCH-01. The company was founded by Kevin McElwee and Rolf Hoffmann on April 24, 1967 and is headquartered in Vancouver, Canada.

Contact Data
Trying to get in touch with decision makers at RepliCel Life Sciences, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President, Chief Executive Officer, Secretary & Director

Director of Finance & Chief Financial Officer

Chief Scientific Officer

Chief Medical Officer

Corporate Secretary

Canadian Investor Relations Consultant

Executive Officer

Board of Directors

Former President, Chief Executive Officer & Director at RepliCel Life Sciences, Inc.

President, Chief Executive Officer, Secretary & Director at RepliCel Life Sciences, Inc.

Chairman-Finance at Marine Drive Golf Club

Director at RepliCel Life Sciences, Inc.

Director at RepliCel Life Sciences, Inc.

Paths to RepliCel Life Sciences, Inc.
Potential Connections via
Relationship Science
You
RepliCel Life Sciences, Inc.
Recent Transactions
Details Hidden

RepliCel Life Sciences, Inc. raised money in a private placement transaction

Details Hidden

RepliCel Life Sciences, Inc. raised money in a private placement transaction

Details Hidden

RepliCel Life Sciences, Inc. raised money in a private placement transaction

Advisors & Consultants
Consultant

Former Chief Financial Officer at RepliCel Life Sciences, Inc.

Clients

Shiseido Co., Ltd. engages in the production and sale of cosmetics for men and women. It operates through the following segments: Japan, China, Asia Pacific, Americas, Europe, Travel Retail, Professional, and Others. The Japan, China, Asia Pacific, Americas, and Europe segments sell cosmetics, fragrance, and personal care products with core brands such as Shiseido, clé de peau BEAUTÉ, ELIXIR, MAQUILLAGE, AUPRES, urara, TSUBAKI, Za, and narciso rodriguez in each corresponding region. The Travel Retail segment retails Shiseido, clé de peau BEAUTÉ, bareMinerals, and NARS brands in airport duty-free shops excluding Japan. The Professional segment manages the sale of beauty products in Japan, China, and Asia. The Others segment includes headquarter functions, production, frontier science, and restaurant businesses. The company was founded by Arinobu Fukuhara on September 17, 1872 and is headquartered in Tokyo, Japan.

Key Stats and Financials As of 2020
Market Capitalization
$7.71M
Total Enterprise Value
$5.18M
Earnings Per Share
$-0.05
TEVNet Income
-4.25x
Debt TEV
0.08x
EBITDAMargin
-381.3%
Enterprise Value / Sales
18.98x
Revenue
$273K
Net Profit
$-1.22M
EBITDA
$-1.04M
Total Debt
$436K
Total Equity
$-3.9M
Suppliers
A.M.I. Agency for Medical Innovations GmbH Holding Companies | Feldkirch, Austria

A.M.I. Agency for Medical Innovations GmbH develops surgical products for the fields of general surgery and morbid obesity surgery. Its services include coloproctology, bariatric surgery, urogynaecology, urology, laparoscopy and infusion port systems. The company is headquartered in Feldkirch, Austria.

Art of Technology AG Zurich, Switzerland

Competitors
Castle Creek Pharmaceuticals LLC Pharmaceuticals - Basking Ridge, NJ

Castle Creek Pharmaceuticals LLC operates as a biopharmaceutical company. It develops drugs for genetic rare diseases. It focuses on developing and commercializing new treatment options for patients with the unmet medical need. The company was founded by Michael Derby and Jeffrey S. Aronin in 2015 and is headquartered in Parsippany, NJ.

Follica, Inc. Consumer Services - Boston, MA

Follica, Inc. develops therapies for hair follicle disorders. The firm provides an out-patient therapy coupled with an at-home system for the treatment of androgenetic alopecia (hair loss) and medical device development fields to develop and commercialize its product platform. The company was founded by Rox R. Anderson, George Cotsarelis, Vera Price, Daphne Zohar, David Steinberg, and Bernat Olle in 2006 and is headquartered in Boston, MA.

Orthocell Ltd. Medical Support Services - Murdoch, Australia

Orthocell Ltd. engages in the development and commercialization of cell therapies and related technologies. Its products include CelGro which derives collagen medical device for soft tissue repair, and Antilogous Tenocyte Implantation (Ortho-ATI) for chronic, treatment resistant tendon injuries. The company was founded by Paul Anderson and Min Hao Zheng on March 21, 2006 and is headquartered in Murdoch, Australia.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by RepliCel Life Sciences, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of RepliCel Life Sciences, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and RepliCel Life Sciences, Inc..